Sir,

A 32-year-old male presented with the complaints of multiple, gradually progressive, painless, dark-colored, symmetrical, retroauricular swellings for the past 10 years. Swelling initially appeared behind the left ear for which he underwent complete surgical excision, but there was gradual recurrence of similar swellings behind the left ear, left cheek, left side of the jaw, and also behind the right ear over the next 6 years. The patient complained of heaviness over the head, had difficulty in lying down sideways, and also had low self-esteem due to the facial disfigurement. There was no history of itchy rash over the body, grittiness or watering of eyes, nasal blockage, dyspnea, cough, chest pain, or wheeze.

On examination, there was significant lymphadenopathy in the form of multiple nontender, discrete, soft-to-firm, freely mobile lymph nodes (LNs) over submental, submandibular cervical, axillary and inguinal regions varying in size from 0.5 to 1.5 cm which were not fixed to underlying structures or overlying skin. Systemic examination was essentially normal.

Dermatological examination revealed multiple, skin-colored to hyperpigmented masses over the left parotid, left submandibular region, and bilateral retroauricular regions measuring 18 cm × 8 cm over the left side, and 12 cm × 8 cm and 2 cm × 2 cm on the right side which were discrete, soft-to-doughy in consistency, nontender, nonfluctuant, and nontransilluminant with normal local temperature \[Figure [1a](#F1){ref-type="fig"} and [b](#F1){ref-type="fig"}\]. Swellings were adherent to overlying skin and fixed to underlying structures.

![(a and b) Multiple skin colored to hyperpigmented masses symmetrically over bilateral retroauricular regions](IJD-65-155-g001){#F1}

Investigations revealed eosinophilia of 41% on peripheral blood smear with absolute eosinophil count of 5230/mm^3^. Serum immunoglobulin E (IgE) was 3285 kU/L. Serum biochemistry and urine examination including 24-h urinary protein were within the normal range. Fine-needle aspiration cytology of the left cervical LN showed reactive lymphadenitis.

Biopsy from mass over the right ear revealed normal epidermis. Dermis showed numerous blood vessels lined by plump endothelial cells. A few lymphoid follicles with germinal centers were noted with mixed inflammatory infiltrate consisting of lymphocytes and eosinophils \[Figure [2a](#F2){ref-type="fig"} and [b](#F2){ref-type="fig"}\]. On IHC, CD3-positive T-cells, CD20-positive B-cells, and CD34-positive blood vessels were highlighted \[Figure [3a](#F3){ref-type="fig"}-[c](#F3){ref-type="fig"}\].

![(a) Skin biopsy from the right retroauricular mass revealed dermis consisting of multiple lymphoid follicles with the germinal centers (H and E ×100). (b) The view shows that well-defined lymphoid follicle with mixed inflammatory infiltrate consisting of lymphocytes and eosinophils (H and E ×200)](IJD-65-155-g002){#F2}

![(a) CD20 positive B-cells were seen in the lymphoid follicles (IHC, ×100). (b) CD3 positive T-cells highlighted in the extrafollicular region (IHC, ×100). (c) Multiple CD34 positive cells highlighting the endothelial cells of the blood vessels (IHC, ×100)](IJD-65-155-g003){#F3}

Chest X-ray suggested right paratracheal lymphadenopathy. Magnetic resonance imaging (MRI) of the head-and-neck region revealed heterogeneous intensity lesions on T2W1 in the subcutaneous tissue of both retroauricular regions (L \> R) extending into the left parotid region but seen separately from the left parotid and muscles of mastication. Magnetic resonance angiography revealed the absence of vascular supply to the lesions. To rule out any underlying vascular malformations, a Doppler ultrasound was done that showed heterogeneous echogenicity lesions with anechoic vascular channels in both the retroauricular regions extending along the parotid region and the soft tissues of the neck. However, no flow was demonstrated in these anechoic vascular channels on Doppler study. Ultrasonography of the neck also showed multiple, enlarged cervical, and intraparotid LNs. Computed tomography (CT) of the head and neck confirmed the findings of retroauricular masses and highlighted the intraparotid and cervical LNs in the anterior and posterior triangles of the neck \[Figure [4a](#F4){ref-type="fig"}-[c](#F4){ref-type="fig"}\]. Platelet-derived growth factor receptor alpha (PDGFRA) gene mutation study was negative.

![(a) Computed tomography scan of the head and neck showed retroauricular masses and highlighted the intraparotid and cervical lymph nodes in the anterior and posterior triangles of the neck. (b and c) Magnetic resonance imaging of the head-and-neck region revealed that heterogeneous intensity lesions on T2-weighted image in the subcutaneous tissue of both retroauricular regions (L \> R) extending into the left parotid region, but seen separately from the left parotid and muscles of mastication](IJD-65-155-g004){#F4}

Based on the clinical findings and investigations, he was managed as a case of Kimura\'s disease (KD) with tapering doses of tablet methylprednisolone at the dose of 1 mg/kg body weight daily with the addition of cyclosporine as maintenance therapy.

The patient showed significant reduction in the size of all masses after 2 weeks of therapy \[[Figure 5](#F5){ref-type="fig"}\]. Investigations done after 2 weeks showed resolution of the right paratracheal lymphadenopathy. Ultrasound of the neck showed significant reduction in vascularity of lesions and cervical lymphadenopathy.

![Marked reduction in size of the retroauricular masses at day-21 posttherapy](IJD-65-155-g005){#F5}

He was not offered Imatinib mesylate as his PDGFRA gene mutation study was negative. At present, the patient is under regular follow-up.

Kimura disease (KD) is a rare, chronic inflammatory disease of unknown etiology causing subcutaneous swellings, and lymphadenopathy affecting commonly men of Asian origin in the second to third decades of life. It was first described in 1937 by Kim in China as "eosinophilic hyperplastic lymphogranuloma."\[[@ref1]\] It later came to be known as KD after Kimura *et al.* reported their findings in many Japanese men.\[[@ref2]\] Peripheral blood eosinophilia and increase in serum IgE levels are commonly seen.\[[@ref1][@ref2]\]

The etiology of KD is unknown. The presence of eosinophilia and increased IgE, tumor necrosis factor-α, interleukin-4 (IL-4), IL-5, and IL-13, and mast cell levels both in peripheral blood and in lesional tissue denote an allergic reaction or an alteration of immune system.\[[@ref3]\] Autoimmune, infective, and neoplastic etiologies have also been proposed; however, exact cause is still elusive.\[[@ref3]\] Ebstein--Barr virus, human herpesvirus-8, *Candida albicans*, insect bites, and parasitic infection leading to persistent antigenic stimulus has been mentioned.\[[@ref4]\] KD in a hemodialysis patient has been reported in the literature.\[[@ref5]\]

KD can affect the kidneys in approximately 20%--60% of cases presenting generally as nephrotic syndrome with albuminuria; however, it can manifest as all types of glomerulonephritis too.\[[@ref6]\]

The common sites for the nodules and subcutaneous masses are preauricular, submandibular, parotid, oral cavity, larynx, groin, epicranium, and popliteal regions. Other rare sites include the axilla, oral cavity, and nasal sinuses. Regional LNs and salivary glands are usually involved.\[[@ref7]\]

Definitive diagnosis is based on the histological picture of germinal center hyperplasia, intact nodal morphology, postcapillary venule proliferation, and eosinophilic infiltrates. Other frequent findings include multinucleated giant cells, sclerosis, eosinophilic microabscesses, necrosis, and vascular proliferation. Immunofluorescence shows germinal centers containing heavy IgE deposits.

KD is commonly confused with angiolymphoid hyperplasia with eosinophilia (ALHE). ALHE is an uncommon, vasoproliferative, idiopathic condition-related to inflammatory stimulation, affecting middle-aged, western women. Generally presents with a superficial well-circumscribed mass with histology showing proliferation of blood vessels with distinctive large endothelial cells. ALHE is now considered to be a type of histiocytoid hemangioma. Patients with ALHE have normal IgE levels and no albuminuria.\[[@ref2]\]

Among the imaging modalities, ultrasound generally reveals hypoechoic, solid, and round areas. Radiologically, since KD tends to mimic many chronic and malignant disorders such as tuberculosis and lymphoma, histopathological diagnosis becomes very important. CT and MRI are very useful in demonstrating the extent of gland and LN involvement like in our case.

There is no definitive treatment till date for KD. Treatment aims to preserve function and esthetics while preventing recurrences. In asymptomatic cases, conservative observation is adequate as lesions sometimes undergo spontaneous resolution. Surgical excision is considered as first line of the treatment in symptomatic cases, though recurrence is common.\[[@ref8]\] Topical, intralesional, and systemic steroids are frequently used, but the swellings may become refractory to the treatment.\[[@ref9]\] Radiotherapy (20--45 Gy) is also effective, and cyclosporine (5 mg/kg/day) has shown good results in many studies.\[[@ref8][@ref9]\]

Imatinib mesylate is now being considered as an effective treatment for KD. As an inhibitor of the protein-tyrosine kinases (PTK), imatinib works by selectively blocking PTK, such as PDGFR and c-Kit.\[[@ref10]\] Azathioprine, all-trans retinoic acid, leflunomide, pentoxifylline, pranlukast, and intravenous immunoglobulin have been tried with variable response.

However, the prognosis of KD is excellent, and the disease has no potential for malignancy. This case is hereby reported, because of its rarity and excellent response to therapy.
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